What is NDC 70518-3766?

70518-3766 is the product NDC for Lorazepam, Lorazepam 2 mg/mL injection, solution, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.

REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lorazepam?

135 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lorazepam NDC 70518-3766 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-3766Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-3766Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-3766-0	70518376600	10 CARTRIDGE in 1 CARTON (70518-3766-0) / 1 mL in 1 CARTRIDGE (70518-3766-1)Marketed from Aug 1, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lorazepam
Generic name (nonproprietary): lorazepam
Active ingredients: Lorazepam — 2 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: REMEDYREPACK INC.NDC labeler code 70518
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074243
Marketing start: Aug 1, 2018
Listing expires: Dec 31, 2027
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 70518-3766_593f032b-81e9-1f79-e063-6394a90ac7a7SPL ID 593f032b-81e9-1f79-e063-6394a90ac7a7SPL set ID 5a02c97d-637d-43f7-803c-afe4381ccc59RxCUI 763028UNII O26FZP769L
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470518376600 followed by a unit qualifier and the quantity

Package 70518-3766-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 17, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Status Epilepticus Lorazepam injection is indicated for the treatment of status epilepticus. Preanesthetic Lorazepam injection is indicated in adult patients for preanesthetic medication, producing sedation (sleepiness or drowsiness), relief of anxiety, and a decreased ability to recall events related to the day of surgery. It is most useful in those patients who are anxious about their surgical procedure and who would prefer to have diminished recall of the events of the day of surgery (see PRECAUTIONS, Information for Patients ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70518-3766

What is NDC 70518-3766?: 70518-3766 is the product NDC for Lorazepam, Lorazepam 2 mg/mL injection, solution, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lorazepam.
What is the active ingredient?: Lorazepam.
Who is the labeler?: REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lorazepam?: 135 other product NDCs are listed under this name. See all Lorazepam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lorazepam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lorazepam	Lorazepam 1 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-091	87441-0091-01
Lorazepam	Lorazepam 1 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4180	68788-4180-0168788-4180-0368788-4180-06+2 more
Lorazepam	Lorazepam .5 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-947	60760-0947-02
Lorazepam	Lorazepam 1 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-948	60760-0948-02
Lorazepam	Lorazepam .5 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-050	87441-0050-01
Lorazepam	Lorazepam 2 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-051	87441-0051-01
Lorazepam	Lorazepam 1 mg/1	TabletOral	Coupler LLC	67046-0230	67046-0230-03
Lorazepam	Lorazepam .5 mg/1	TabletOral	Coupler LLC	67046-0786	67046-0786-03
Lorazepam	Lorazepam 2 mg/1	TabletOral	Coupler LLC	67046-0936	67046-0936-03
Lorazepam	Lorazepam 2 mg/mL	LiquidOral	American Health Packaging	68000-108	68000-0108-05

All 136 Lorazepam NDCs

Other NDCs under ANDA 074243

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074243
Product	Strength	Form · route	Labeler	Product NDC
Lorazepam	Lorazepam 2 mg/mL	Injection, SolutionIntramuscular, Intravenous	Hospira, Inc.	0409-1985